The Journal of Dietary Supplements is planning a special issue devoted to the toxicology, pharmacology, and potential regulatory pathways for CBD and other cannabinoids, and is inviting submissions.
Introducing user fees for the food industry – of which dietary supplements are a subset – is a tough proposition, says Dan Fabricant, president and CEO of the Natural Products Association.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
Novel ingredients in the sports nutrition space come along once a decade, and the real innovation for the category comes from finding new combinations of tried and true ingredients to maximize effects, says Jim Stoppani, PhD, Founder of JYM Supplement...
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
Legislative challenges to dietary supplements and opportunities for regulatory fine tuning continue even as the industry is distracted, said Steve Mister of CRN.
The United States Department of Agriculture has issued its eagerly anticipated draft rule on hemp cultivation. The rule is viewed as largely consistent with many of the state rules already in place.
Colorado-based Quicksilver Scientific has joined the CBD bioavailability game with a new product line featuring the company’s proprietary liposomal delivery system.
The 20th annual Oxford International Conference on the Science of Botanicals is now accepting abstract submissions. The event is held March 30th - April 2nd, 2020 in Oxford, Mississippi.
A Colorado-based producer of bulk hemp-derived CBD products, backed by an ambitious state government plan, is looking south to new markets in Latin America.
A rush to market for CBD has left the terpenes in hemp out in the cold. An expert in the space said there is much potential benefit yet to be discovered in these fractions of the plant.
